Assembly Biosciences Inc (ASMB)
17.05
+0.35
(+2.10%)
USD |
NASDAQ |
Nov 14, 16:00
16.79
-0.26
(-1.52%)
After-Hours: 20:00
Assembly Biosciences Cash from Financing (Quarterly): 12.45M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 12.45M |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 9.192M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.134M |
| March 31, 2023 | 4.492M |
| December 31, 2022 | 0.437M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.177M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 2.713M |
| September 30, 2021 | 10.06M |
| June 30, 2021 | 6.159M |
| March 31, 2021 | 34.14M |
| December 31, 2020 | 5.687M |
| September 30, 2020 | 0.843M |
| June 30, 2020 | 0.95M |
| March 31, 2020 | 0.119M |
| December 31, 2019 | 137.42M |
| September 30, 2019 | 1.385M |
| June 30, 2019 | 0.706M |
| March 31, 2019 | 0.14M |
| December 31, 2018 | 0.605M |
| September 30, 2018 | 155.84M |
| June 30, 2018 | 1.85M |
| Date | Value |
|---|---|
| March 31, 2018 | 1.494M |
| December 31, 2017 | 66.23M |
| September 30, 2017 | 0.2629M |
| June 30, 2017 | 0.108M |
| March 31, 2017 | 0.64M |
| December 31, 2016 | 0.153M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.2574M |
| June 30, 2015 | 10.64M |
| March 31, 2015 | 70.67M |
| December 31, 2014 | 14.96M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 1.763M |
| December 31, 2013 | 0.2321M |
| September 30, 2013 | 3.388M |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 20.75M |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 4.716M |
| March 31, 2012 | 0.1807M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2022
137.42M
Maximum
Dec 2019
11.84M
Average
0.95M
Median
Jun 2020
Cash from Financing (Quarterly) Benchmarks
| ADMA Biologics Inc | -25.47M |
| Sensus Healthcare Inc | 0.017M |
| Protagonist Therapeutics Inc | 12.05M |
| Precision BioSciences Inc | 3.733M |
| Entrada Therapeutics Inc | -0.011M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -17.10M |
| Cash from Investing (Quarterly) | 5.107M |
| Free Cash Flow | 24.10M |
| Free Cash Flow Per Share (Quarterly) | -3.033 |
| Free Cash Flow to Equity (Quarterly) | -17.12M |
| Free Cash Flow to Firm (Quarterly) | -17.12M |
| Free Cash Flow Yield | 27.14% |